New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
08:21 EDTAFFX, SQNM, FLDM, PKI, DDXS, WAT, PACBMaxim recommends life science tools, diagnostics ahead of earnings
Maxim expects 2014 to be a "great year" for life science tools and diagnostics stocks and recommends buying Affymetrix (AFFX), diaDexus (DDXS), Fluidigm (FLDM), Pacific Biosciences (PACB), PerkinElmer (PKI), Sequenom (SQNM) and Waters (WAT) ahead of the Q4 results. Maxim has a preference for Pacific Biosciences, PerkinElmer and Waters. The firm raised its price target for Fluidigm to $52 from $42 and for Pacific Biosciences to $9 from $8.
News For AFFX;DDXS;FLDM;PACB;PKI;SQNM;WAT From The Last 14 Days
Check below for free stories on AFFX;DDXS;FLDM;PACB;PKI;SQNM;WAT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
16:12 EDTPACBPacific Biosciences reports Q2 EPS (27c), consensus (28c)
Subscribe for More Information
July 23, 2014
13:39 EDTPKIThermo Fisher Q2 results bode well for PerkinElmer, Bruker, says Mizuho
Subscribe for More Information
July 22, 2014
13:05 EDTWATWaters shares should be bought, says Maxim
Subscribe for More Information
09:49 EDTWATWaters acquires REIMS technology from MediMass
Subscribe for More Information
08:53 EDTWATWaters narrows FY14 EPS view to $5.25-$5.40 from $5.25-$5.50
Consensus is $5.31. Organic sales growth at or above mid single digit range. Sees mid-to-high single digit top line growth in 2H. Sees government funded instrument sales in the U.S. increasing in 2H. Says governmental spending in China beginning to improve. Sees sales growth in Q3, Q4 that would result in FY14 constant currency mid single digit growth. Says still working to find a successor to CEO Douglas Berthiaume. Sees FY operating tax rate 14%-15%. Sees currency neutral to sales growth in FY. Sees FY gross margins 58.5%-59%.
08:52 EDTWATWaters sees Q3 EPS $1.22-$1.32, consensus $1.32
Subscribe for More Information
07:06 EDTWATWaters reports Q2 adjusted EPS $1.22, consensus $1.21
Subscribe for More Information
July 21, 2014
11:21 EDTSQNMSequenom VisibiliT launch unlikely to have near-term impact, says Ladenburg
Subscribe for More Information
07:02 EDTSQNMSequenom subsidiary launched VisibiliT test in international markets
Sequenom announced that its wholly owned subsidiary, Sequenom Laboratories, will soon launch the VisibiliT laboratory-developed test in international markets. The VisibiliT test utilizes maternal age, fetal fraction and the relative amount of chromosomal material for chromosomes 21 and 18 to generate a highly accurate, personalized risk score.
July 17, 2014
10:00 EDTWATOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:31 EDTDDXSdiaDexus announces FDA acceptance for review of 510(k) filing for PLAC test
Subscribe for More Information
06:21 EDTWATWaters initiated with a Neutral at Citigroup
Subscribe for More Information
06:21 EDTPKIPerkinElmer initiated with a Buy at Citigroup
Target $55.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use